Lyssikatos Joseph P — Insider Trades & Holdings | InsiderBid

Lyssikatos Joseph P

Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: -$6.3M

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
ELVN	Enliven Therapeutics, Inc.	$0	$6.3M	-$6.3M	18,750	Feb 12

Enliven Therapeutics, Inc.

-$6.3M

Bought

$0

Sold

$6.3M

Held

18,750

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

All 17 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Trade history

The 28 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Feb 12	ELVN	Enliven Therapeutics, Inc.	AGRANT◆	112,500	—	—	—	Open the original filing on SEC.gov
Feb 12	ELVN	Enliven Therapeutics, Inc.	AGRANT	18,750	—	—	—

ELVNAGRANT◆—

Enliven Therapeutics, Inc.Feb 12

112,500 sh

ELVNAGRANT—

Enliven Therapeutics, Inc.Feb 12

18,750 sh

ELVNSSELL◷$145.2K

Enliven Therapeutics, Inc.Feb 6

5,000 sh @ $29.04 · -0.7% own

ELVNSSELL◷$390.3K

Enliven Therapeutics, Inc.Jan 20

14,509 sh @ $26.90 · -1.9% own

ELVNSSELL◷$144.8K

Enliven Therapeutics, Inc.Jan 20

5,491 sh @ $26.37 · -0.7% own

ELVNSSELL◷$1.5M

Enliven Therapeutics, Inc.Jan 9

50,000 sh @ $29.13 · -6.1% own

ELVNSSELL◷$1M

Enliven Therapeutics, Inc.Jan 9

41,198 sh @ $24.90 · -4.8% own

ELVNSSELL◷$842.5K

Enliven Therapeutics, Inc.Jan 8

33,802 sh @ $24.92 · -3.8% own

ELVNSSELL◷$151K

Enliven Therapeutics, Inc.Jan 8

7,500 sh @ $20.13 · -0.8% own

ELVNSSELL◷$84.2K

Enliven Therapeutics, Inc.Dec 19, 2025

5,000 sh @ $16.84 · -0.5% own

ELVNSSELL◷$11.4K

Enliven Therapeutics, Inc.Nov 19, 2025

492 sh @ $23.09 · <0.1% own

ELVNSSELL◷$267.8K

Enliven Therapeutics, Inc.Nov 19, 2025

12,008 sh @ $22.30 · -1.3% own

ELVNSSELL◷$276K

Enliven Therapeutics, Inc.Oct 20, 2025

12,500 sh @ $22.08 · -1.4% own

ELVNSSELL◷$81K

Enliven Therapeutics, Inc.Sep 26, 2025

4,000 sh @ $20.25 · -0.4% own

ELVNSSELL◷$30K

Enliven Therapeutics, Inc.Sep 23, 2025

1,500 sh @ $20.03 · -0.2% own

ELVNSSELL◷$42.6K

Enliven Therapeutics, Inc.Sep 19, 2025

2,130 sh @ $20.02 · -0.2% own

ELVNSSELL◷$93.1K

Enliven Therapeutics, Inc.Sep 19, 2025

4,870 sh @ $19.11 · -0.5% own

ELVNSSELL◷$150.1K

Enliven Therapeutics, Inc.Aug 21, 2025

7,500 sh @ $20.01 · -0.8% own

ELVNSSELL◷$98.1K

Enliven Therapeutics, Inc.Aug 19, 2025

5,000 sh @ $19.62 · -0.5% own

ELVNSSELL◷$13.2K

Enliven Therapeutics, Inc.Jul 21, 2025

576 sh @ $22.90 · <0.1% own

ELVNSSELL◷$265.5K

Enliven Therapeutics, Inc.Jul 21, 2025

11,924 sh @ $22.26 · -1.2% own

ELVNSSELL◷$267.5K

Enliven Therapeutics, Inc.Jun 20, 2025

12,500 sh @ $21.40 · -1.3% own

ELVNSSELL◷$150.2K

Enliven Therapeutics, Inc.Jun 3, 2025

7,500 sh @ $20.03 · -0.8% own

ELVNSSELL◷$81.5K

Enliven Therapeutics, Inc.May 19, 2025

5,000 sh @ $16.31 · -0.5% own

ELVNSSELL◷$49.4K

Enliven Therapeutics, Inc.May 2, 2025

2,470 sh @ $20.01 · -0.3% own

ELVNSSELL◷$101K

Enliven Therapeutics, Inc.May 1, 2025

5,030 sh @ $20.07 · -0.5% own

ELVNSSELL◷$5.5K

Enliven Therapeutics, Inc.Apr 21, 2025

330 sh @ $16.72 · <0.1% own

ELVNSSELL◷$74.8K

Enliven Therapeutics, Inc.Apr 21, 2025

4,670 sh @ $16.03 · -0.5% own